e-learning
resources
Milan 2017
Sunday, 10.09.2017
Current challenges in COPD evaluation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled breath temperature in patients with severe asthma starting treatment with omalizumab
T. Kralimarkova (Sofia, Bulgaria)
Source:
International Congress 2017 – Current challenges in COPD evaluation
Session:
Current challenges in COPD evaluation
Session type:
Poster Discussion
Number:
404
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Kralimarkova (Sofia, Bulgaria). Exhaled breath temperature in patients with severe asthma starting treatment with omalizumab. 404
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Endothelin -1 in exhaled breath condensate during omalizumab therapy in patients with severe persistent allergic asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Exhaled breath temperature in COPD patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients
Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation
Year: 2012
Exhaled breath temperature in children with chronic cough
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Exhaled breath temperature in asthma
Source: Eur Respir J 2003; 21: 195
Year: 2003
Exhaled breath temperature gradients are reduced in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 301s
Year: 2002
Increased exhaled breath temperature in subjects with non-controlled asthma
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Exhaled breath temperature increases at COPD exacerbation and correlates with sputum neutrophilia
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Il-6 levels in exhaled breath condensate (EBC) of children with moderate well-controlled asthma stepping down inhaled corticosteroids
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Exhaled NO predicts relapse after discontinuation of inhaled steroids in asthmatic children
Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma
Year: 2003
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Exhaled bimarkers in exacerbation of COPD
Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Year: 2007
Effect of tiotropium on exhaled breath temperature in patients with COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 619s
Year: 2006
Exhaled breath histamine is reduced following methacholine challenge in patients with mild asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 165s
Year: 2001
Exhaled NO (FENO) is superior to peak-flow monitoring in predicting exacerbation in asthmatics
Source: Eur Respir J 2005; 26: Suppl. 49, 118s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept